Location History:
- Nova Scotia, CA (1992 - 1993)
- Montreal, CA (1981 - 1994)
- Kentville, Nova Scotia, CA (1989 - 1997)
Company Filing History:
17 out of 33 
1 out of 1 
5 out of 832,812 Years Active: 1981-1997
Title: Innovations in Skin Treatment: The Contributions of David F Horrobin
Introduction: David F Horrobin is a prominent inventor based in Montreal, Canada, known for his significant contributions to the field of dermatology through innovative treatments. With a total of 23 patents to his name, Horrobin has dedicated his career to developing groundbreaking methods and compositions aimed at improving skin health.
Latest Patents: Among his latest patents, Horrobin has made strides with his invention related to methods and compositions for the treatment of seborrheic dermatitis. This invention describes a method involving the topical application of a composition containing an excipient and lithium ions, aimed at reducing sebum production in affected skin. Additionally, his work includes a method for enhancing 1-series prostaglandin (PG) production, utilizing gamma-linolenic acid and potentially other fatty acids, in conjunction with natural or synthetic carotenoids or retinoids, to promote therapeutic effects in conditions requiring a favorable balance of 1-series PGs.
Career Highlights: Throughout his career, Horrobin has been associated with various companies, including Efamol Limited, contributing his expertise in research and development. His innovative approaches have not only advanced the understanding of skin treatments but have also provided new options for patients suffering from dermatological conditions.
Collaborations: Horrobin has collaborated with notable professionals in his field, including Julian Lieb, enhancing the impact and reach of his innovations. These partnerships have fostered an environment of shared knowledge and advancement in dermatology.
Conclusion: David F Horrobin's work exemplifies the spirit of innovation and dedication within the realm of skin treatment. His extensive patent portfolio underscores a commitment to improving dermatological health through scientifically-grounded methods. As new advancements emerge, Horrobin's contributions continue to inspire future research in the field.